Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

Electrocardiogram tests – which measure the heart's electrical activity – could someday be paired with an artificial ...

Trusting which data to use and what can be deleted still requires human oversight; startups are at a disadvantage.

Recent advancements in AI have made it possible to infer personality traits from a single photograph of a person’s face. A ...

Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Researchers aim to validate the AI tool SCORPIO in prospective studies and eventually seek FDA clearance to sell it as a commercial tool in the US.

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...

The real power of a digital twin lies in its interactivity. Operators can interact with the model to test hypothetical ...

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of ...

Taylor Rapp’s status for the AFC Championship remains uncertain as the Buffalo Bills prepare to face the Kansas City Chiefs ...

A international joint research team of KAIST and the University of Michigan developed a digital biomarker for predicting ...